Press Releases

Date Title and Summary Additional Formats
Toggle Summary Strong Revenue For Q4 - Full Year 2013 Revenue Up 36%
For Immediate Release
View HTML
Toggle Summary Fluidigm at the Cowen and Co. Annual Health Care Conference
Fluidigm to Present at the Cowen and Company 34th Annual Health Care Conference   SOUTH SAN FRANCISCO, Calif. – Feb. 26, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced that it will present at the Cowen and Company 34th Annual Health Care Conference in Boston, on Tuesday, March 4, 2014,
View HTML
Toggle Summary Fluidigm Completes Acquisition Of DVS Science
High-Parameter Single-Cell Protein Analysis Platform Joins With Industry-Leading...
View HTML
Toggle Summary Strong Revenue For Q4 - Full Year 2013 Revenue Up 36%
Fluidigm Reports Strong Revenue for Q4 and the Full Year 2013 - Full Year 2013 Revenue Up 36%   SOUTH SAN FRANCISCO, Calif. – February 6, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the fourth quarter and full year ended December 31, 2013.
View HTML
Toggle Summary Pricing Of $175 Million Convertible Senior Notes Offering
Fluidigm Announces Pricing of $175 Million Convertible Senior Notes Offering   SOUTH SAN FRANCISCO, CALIFORNIA, – January 30, 2014 – Fluidigm Corporation (NASDAQ: FLDM), a supplier of microfluidic systems for growth markets in the life science and agricultural biotechnology industries, today
View HTML
Toggle Summary Q4/Full Year 2013 Financial Results
Fluidigm to Announce Q4/Full Year 2013 Financial Results and Host Conference Call for Investors   SOUTH SAN FRANCISCO, Calif., Jan. 31, 2014 — Fluidigm Corporation (NASDAQ:FLDM) will report its fourth quarter and 2013 full year financial results on February 6, 2014, after close of market.
View HTML
Toggle Summary Fluidigm To Acquire DVS Sciences
Combines DVS Sciences' High-Parameter Single-Cell Protein Analysis Platform with...
View HTML
Toggle Summary Proposed $175 Million Convertible Senior Notes Offering
Fluidigm Announces Proposed $175 Million Convertible Senior Notes Offering    SOUTH SAN FRANCISCO, CALIFORNIA – January 29, 2014 – Fluidigm Corporation (NASDAQ: FLDM), a supplier of microfluidic systems for growth markets in the life science and agricultural biotechnology industries, today
View HTML
Toggle Summary Fluidigm Announces Preliminary Fourth Quarter 2013 Revenue
Fluidigm Announces Preliminary Fourth Quarter 2013 Revenue and Issues 2014 Revenue Guidance   SOUTH SAN FRANCISCO, Calif. – Jan. 14, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced total revenue for the fourth quarter of 2013 is expected to be approximately $21 million based on
View HTML
Toggle Summary Fluidigm at 32nd Annual J.P. Morgan Healthcare Conference
Fluidigm to Present at the 32nd Annual J.P. Morgan Healthcare Conference    SOUTH SAN FRANCISCO, Calif. – Jan. 8, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced that President and Chief Executive Officer Gajus Worthington will present at the 32nd Annual J.P.
View HTML